At the World Ophthalmology Congress 2024 (WOC 2024), I had the rare honour of being invited to teach an hour-long instruction course on Clinical Low Vision to an international audience. As the chief instructor, I had the privilege of tailoring this course to meet the needs of a global audience. To ensure a well-rounded and fruitful experience, I invited esteemed experts Dr. Miguel Morcillo [Moorfields Eye Hospital, Dubai] and Dr. S. Natrajan [Aditya Jyot Eye Hospital, Mumbai] to join me as co-instructors.

There are numerous eye diseases for which there are currently no medical or surgical treatments available to improve vision and alleviate blindness. Such patients with extremely poor residual vision are technically described as having “Low Vision.” Globally, approximately 246 million people are living with low vision. This is a huge number that far exceeds the number of patients who are totally blind.

My course on August 17, focused on equipping participants with the skills to enhance their patients’ residual vision by prescribing optical, non-optical, and non-visual devices. By doing so, they can significantly benefit a large number of their legally blind patients, restoring their functionality and enabling them to lead independent and productive lives.

The course was very well received and culminated in a lively Q&A session, where participants posed a wide variety of questions. I would like to extend my heartfelt thanks to my co-instructors, Dr. Morcillo and Dr. Natrajan, for their invaluable contributions in making this course a resounding success.

To learn more about our non-profit work and lend a helping hand, please visit our website